Shein AMS, Wannigama DL*, Hurst C, Monk PN, Amarasiri M, Badavath VN, Phattharapornjaroen P, Ditcham WGF, Ounjai P, Saethang T, Chantaravisoot N, Thuptimdang W, Luk-in S, Nilgate S, Rirerm U, Tanasatitchai C, Kueakulpattana N, Laowansiri M, Liao T, Kupwiwat R, Rojanathanes R, Ngamwongsatit N, Thammahong A, Ishikawa H, Pletzer D, Leelahavanichkul A, Ragupathi NKD, Wapeesittipan P, Ali Hosseini Rad SM, Kanjanabuch T, Storer RJ, Miyanaga K, Cui L, Hamamoto H, Higgins PG, Kicic A*, Chatsuwan T*, Hongsing P*, Abe S*. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating
Pseudomonas aeruginosa lung infection.
Biomed Pharmacother 2023 Dec;168:115793. Source Type: Journals / Doc.Type: Article
Gold OA